About Ed

Ed is an Investment Director at Future Planet Capital where he manages the Blue Ocean fund and sits on the Investment Committees for flagship Future Planet Capital funds and the UK Innovation and Science Seed Fund. He is a Director at Captura, and has led investments into companies including NeoVac, Queen of Raw, Vaarst/RovCo., Aria Pharmaceuticals, Navenio and Vaccitech (NASDAQ) the Oxford spin-out behind the COVID-19 vaccine with 3 billion doses now made available worldwide.

As part of the founding team at Future Planet Capital, he helped grow the firm from a $20M experiment fund to over $400m in committed capital today. He has led investments for a number of strategies, including a Pandemic response micro-fund with Barclays, followed by an ocean focussed fund for the government of Monaco. He also developed Future Planet Capital’s partnership with Seedrs to become the first VC firm to democratise investment into its management company.

Ed has previously been a Venture Fellow and Scout for a leading US deeptech accelerator and the UK's most active seed investor. Before Future Planet Capital he spent time researching molecular genetics at Hong Kong University and received a 1st (Hons) in Biological Sciences at Bristol University, where he was President of Bristol Think and joint first for the Liv Sidse Jansen Prize for his work into the impact of Climate Change on marine ecosystems.